Immunotherapy in Combination with Chemotherapy for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks estrogen and progesterone receptors and does not overexpress the human epidermal growth factor receptor 2 (HER2). Previous treatment options for TNBC were limited to chemotherapy alone, resulting in a poor pati...
Gorde:
| Beste egile batzuk: | , , |
|---|---|
| Formatua: | Artículo |
| Hizkuntza: | en_US |
| Argitaratua: |
2023
|
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.2174/1389557523666230517152538 https://pubmed.ncbi.nlm.nih.gov/37198990/ |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
